|
IL160406A0
(en)
|
1995-06-15 |
2004-07-25 |
Crucell Holland Bv |
A cell harbouring nucleic acid encoding adenoritus e1a and e1b gene products
|
|
US20030022293A1
(en)
*
|
1997-09-18 |
2003-01-30 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6391311B1
(en)
*
|
1998-03-17 |
2002-05-21 |
Genentech, Inc. |
Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
|
|
US7371836B2
(en)
*
|
1998-03-27 |
2008-05-13 |
Genentech, Inc. |
PRO526 nucleic acids
|
|
US7723488B2
(en)
*
|
1998-03-27 |
2010-05-25 |
Genentech, Inc. |
Monoclonal antibodies to secreted and transmembrane polypeptides
|
|
US20070020724A1
(en)
|
1998-06-16 |
2007-01-25 |
Ruben Steven M |
94 human secreted proteins
|
|
CA2331154A1
(en)
|
1998-06-16 |
1999-12-23 |
Human Genome Sciences, Inc. |
Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
|
|
US6936697B2
(en)
*
|
1998-09-01 |
2005-08-30 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7399834B2
(en)
*
|
1998-10-07 |
2008-07-15 |
Genentech, Inc. |
Anti-PRO1558 antibodies
|
|
US7026449B2
(en)
*
|
1999-01-05 |
2006-04-11 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
PT1626058E
(pt)
*
|
1999-03-08 |
2008-02-15 |
Genentech Inc |
Composições e métodos para o diagnóstico de tumores
|
|
US20050164386A1
(en)
*
|
1999-04-15 |
2005-07-28 |
Uytdehaag Alphonsus G. |
Overexpression of enzymes involved in post-translational protein modifications in human cells
|
|
US7604960B2
(en)
*
|
1999-04-15 |
2009-10-20 |
Crucell Holland B.V. |
Transient protein expression methods
|
|
US6855544B1
(en)
*
|
1999-04-15 |
2005-02-15 |
Crucell Holland B.V. |
Recombinant protein production in a human cell
|
|
US8236561B2
(en)
*
|
1999-04-15 |
2012-08-07 |
Crucell Holland B.V. |
Efficient production of IgA in recombinant mammalian cells
|
|
US7297680B2
(en)
*
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
|
US20060099685A1
(en)
*
|
1999-04-15 |
2006-05-11 |
Yallop Christopher A |
Recombinant expression of factor VIII in human cells
|
|
AU3632600A
(en)
*
|
1999-05-14 |
2000-12-05 |
Genentech Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US20050079577A1
(en)
*
|
1999-05-14 |
2005-04-14 |
Ashkenazi Avi J. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6500940B1
(en)
|
1999-06-09 |
2002-12-31 |
The Salk Institute For Biological Studies |
Lifeguard (LFG) polynucleotides and polypeptides and methods of use thereof
|
|
US6114123A
(en)
*
|
1999-06-14 |
2000-09-05 |
Incyte Pharmaceuticals, Inc. |
Lipocalin family protein
|
|
US6369210B1
(en)
|
1999-06-30 |
2002-04-09 |
Millennium Pharmaceuticals, Inc. |
22012, human carboxypeptidase
|
|
AU5979300A
(en)
*
|
1999-07-02 |
2001-01-22 |
Bayer Aktiengesellschaft |
Angiopoietin-6 and uses thereof
|
|
EP1233777A4
(en)
*
|
1999-11-24 |
2003-07-16 |
Human Genome Sciences Inc |
MAJOR INTRINSIC PROTEIN (MIP) -LIKE POLYNUCLEOTIDES, POLYPEPTIDES AND ANTIBODIES
|
|
US7192759B1
(en)
*
|
1999-11-26 |
2007-03-20 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7521220B2
(en)
*
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7527961B2
(en)
*
|
1999-11-26 |
2009-05-05 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7119165B2
(en)
|
2000-01-12 |
2006-10-10 |
Yale University |
Nogo receptor-mediated blockade of axonal growth
|
|
HK1051543A1
(zh)
*
|
2000-01-12 |
2003-08-08 |
Yale University |
Nogo受体介导的轴突生长封锁
|
|
WO2001060854A1
(en)
*
|
2000-02-14 |
2001-08-23 |
The Regents Of The University Of California |
Novel members of the h+/oligopeptide transporter gene family
|
|
WO2001062929A2
(en)
*
|
2000-02-25 |
2001-08-30 |
Curagen Corporation |
Sodium/solute symporter-like protein and nucleic acids encoding same
|
|
US7070947B2
(en)
|
2000-02-29 |
2006-07-04 |
Millennium Pharmaceuticals, Inc. |
Human protein kinase, phosphatase, and protease family members and uses thereof
|
|
US6531309B1
(en)
*
|
2000-02-29 |
2003-03-11 |
Lexicon Genetics Incorporated |
Human transporter proteins and polynucleotides encoding the same
|
|
WO2001070244A1
(en)
*
|
2000-03-16 |
2001-09-27 |
Northwest Biotherapeutics, Inc. |
Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
|
|
AU2001249929A1
(en)
*
|
2000-04-07 |
2001-10-23 |
Dana-Farber Cancer Institute Inc. |
Fdrg proteins and nucleic acid molecules and uses therefor
|
|
CA2401290A1
(en)
*
|
2000-04-12 |
2001-10-18 |
Takeda Chemical Industries, Ltd. |
Novel g protein-coupled receptor protein and dna thereof
|
|
AU2001253488A1
(en)
*
|
2000-04-14 |
2001-10-30 |
Millennium Pharmaceuticals, Inc. |
33556, a novel human transporter and uses thereof
|
|
EP1280902A2
(en)
*
|
2000-04-29 |
2003-02-05 |
Millennium Pharmaceuticals, Inc. |
23949 and 32391, human ion channels and uses thereof
|
|
US20050170413A1
(en)
*
|
2000-07-03 |
2005-08-04 |
Applera Corporation |
Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
|
|
GB2371546A
(en)
*
|
2000-09-12 |
2002-07-31 |
Smithkline Beecham Corp |
G protein coupled receptor AXOR 109
|
|
CA2420192A1
(en)
*
|
2000-09-20 |
2002-03-28 |
Human Genome Sciences, Inc. |
21 human secreted proteins
|
|
DE60141409D1
(de)
|
2000-10-06 |
2010-04-08 |
Biogen Idec Inc |
Homologe des nogo rezeptors
|
|
US7198914B2
(en)
|
2000-11-17 |
2007-04-03 |
Banyu Pharmaceutical Co., Ltd. |
Guanosine triphosphate (GTP)-binding protein-coupled receptor protein, BG37
|
|
UA79927C2
(en)
*
|
2000-12-05 |
2007-08-10 |
Serono Genetics Inst Sa |
Polynucleotide, coding a polypeptide of potential-depending portal ionic human channel (canion), polypeptyde, antibody, method for identification of candidate modulator of canion-polypeptyde, method for treatment of bipolar disorder or schizophrenia and use of an antibody for production of drugs for treatment of schizophrenia or bipolar disorder
|
|
EP1378749A4
(en)
*
|
2001-04-12 |
2005-05-11 |
Takeda Pharmaceutical |
SCREENING METHOD
|
|
AU2002257273A1
(en)
*
|
2001-04-13 |
2002-10-28 |
Incyte Genomics, Inc. |
Enzymes
|
|
JPWO2002088355A1
(ja)
*
|
2001-04-25 |
2004-08-19 |
藤沢薬品工業株式会社 |
新規なグアノシン三リン酸結合タンパク質共役型の受容体ｐｌａｃｅ６００２３１２およびその遺伝子、並びにそれらの製造および用途
|
|
EP1385962A2
(en)
*
|
2001-05-02 |
2004-02-04 |
Bayer HealthCare AG |
Human prolyl 4-hydroxylases
|
|
CA2447662A1
(en)
*
|
2001-05-25 |
2002-12-05 |
Incyte Genomics, Inc. |
Transporters and ion channels
|
|
CA2399569A1
(en)
*
|
2001-09-25 |
2003-03-25 |
Yusuke Nakamura |
Diagnostic markers and drug targets for treatment of cancer
|
|
US20050123925A1
(en)
|
2002-11-15 |
2005-06-09 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
PT1465987E
(pt)
*
|
2001-12-07 |
2008-04-15 |
Crucell Holland Bv |
Produção de vírus, isolados virais e vacinas
|
|
HUP0501017A3
(en)
*
|
2001-12-14 |
2010-06-28 |
Targacept |
Methods and compositions for treatment of central nervous system disorders
|
|
ES2346868T3
(es)
*
|
2002-08-10 |
2010-10-21 |
Yale University |
Antagonistas de receptor nogo.
|
|
US20040214237A1
(en)
*
|
2002-10-03 |
2004-10-28 |
Synaptic Pharmaceutical Corporation |
DNA encoding SNORF138 and uses thereof
|
|
EA009643B1
(ru)
*
|
2003-04-16 |
2008-02-28 |
Йейл Юниверсити |
Лечение состояний, включающих амилоидные бляшки
|
|
WO2004099396A1
(en)
|
2003-05-09 |
2004-11-18 |
Crucell Holland B.V. |
Cultures of e1-immortalized cells and processes for culturing the same to increase product yields therefrom
|
|
AU2004240782B2
(en)
*
|
2003-05-23 |
2011-04-21 |
Crucell Holland B.V. |
Production of recombinant IGM in per.C6 cells
|
|
BRPI0413426A
(pt)
*
|
2003-08-07 |
2006-10-17 |
Biogen Idec Inc |
antagonistas de receptor novo
|
|
JP2007508020A
(ja)
*
|
2003-09-30 |
2007-04-05 |
カイロン コーポレイション |
ヒトｄｋｋｌ１の新規スプライス改変体
|
|
DE10350409A1
(de)
*
|
2003-10-28 |
2005-05-25 |
Bayer Healthcare Ag |
Behandlung genetisch bedingter Krankheiten
|
|
EP1737435A4
(en)
*
|
2004-02-12 |
2008-06-11 |
Univ Rush Medical Center |
LIQUID COMPOSITION FOR SIMULATING HUMAN SYNOVIAL FLUID
|
|
US7189691B2
(en)
*
|
2004-04-01 |
2007-03-13 |
The Administrators Of The Tulane Educational Fund |
Methods and compositions for treating leukemia
|
|
US7678767B2
(en)
|
2004-06-16 |
2010-03-16 |
Pneumrx, Inc. |
Glue compositions for lung volume reduction
|
|
US20050281740A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Imaging damaged lung tissue
|
|
US7608579B2
(en)
*
|
2004-06-16 |
2009-10-27 |
Pneumrx, Inc. |
Lung volume reduction using glue compositions
|
|
US7468350B2
(en)
|
2004-06-16 |
2008-12-23 |
Pneumrx, Inc. |
Glue composition for lung volume reduction
|
|
US7553810B2
(en)
*
|
2004-06-16 |
2009-06-30 |
Pneumrx, Inc. |
Lung volume reduction using glue composition
|
|
US20050281798A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Targeting sites of damaged lung tissue using composition
|
|
US20050281739A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Imaging damaged lung tissue using compositions
|
|
CA2570261C
(en)
|
2004-07-08 |
2014-06-10 |
Pneumrx, Inc. |
Pleural effusion treatment device, method and material
|
|
LT1781698T
(lt)
|
2004-07-20 |
2016-09-26 |
Genentech, Inc. |
Į angiopoetiną panašaus baltymo 4 kompozicijos ir panaudojimo būdai
|
|
US8604185B2
(en)
|
2004-07-20 |
2013-12-10 |
Genentech, Inc. |
Inhibitors of angiopoietin-like 4 protein, combinations, and their use
|
|
SI1771474T1
(sl)
*
|
2004-07-20 |
2010-06-30 |
Genentech Inc |
Inhibitorji angiopoetinu podobnega proteina kombinacije in njihova uporaba
|
|
EP1805209A4
(en)
*
|
2004-10-01 |
2008-04-02 |
Univ Yale |
NOGO-A POLYPEPTIDE FRAGMENTS, VARIANT OF NOGO RECEPTOR-1 POLYPEPTIDES AND USE
|
|
US8691780B2
(en)
*
|
2005-02-17 |
2014-04-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
|
|
US8252267B2
(en)
|
2005-03-30 |
2012-08-28 |
Sagres Discovery, Inc. |
DKKL-1 splice product modulators for cancer diagnosis and therapy
|
|
WO2007008732A2
(en)
|
2005-07-07 |
2007-01-18 |
Yale University |
Compositions and methods for suppressing axonal growth inhibition
|
|
US20090062199A1
(en)
*
|
2005-08-25 |
2009-03-05 |
Biogen Idec Ma Inc. |
Nogo Receptor Polypeptides and Polypeptide Fragments and Uses Thereof
|
|
PT1981902E
(pt)
|
2006-01-27 |
2015-11-02 |
Biogen Ma Inc |
Antagonistas dos recetores nogo
|
|
US20110123535A1
(en)
*
|
2006-05-15 |
2011-05-26 |
Biogen Idec Ma Inc. |
Use of Nogo Receptor-1 (NGR1) for Promoting Oligodendrocyte Survival
|
|
US8568286B2
(en)
*
|
2006-06-14 |
2013-10-29 |
Cardiac Pacemakers, Inc. |
Methods to position therapeutic agents using a magnetic field
|
|
WO2008036763A2
(en)
*
|
2006-09-20 |
2008-03-27 |
Pneumrx, Inc. |
Tissue adhesive compositions and methods thereof
|
|
US20090053831A1
(en)
*
|
2007-05-01 |
2009-02-26 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
US20080313166A1
(en)
*
|
2007-06-15 |
2008-12-18 |
Microsoft Corporation |
Research progression summary
|
|
US9128981B1
(en)
|
2008-07-29 |
2015-09-08 |
James L. Geer |
Phone assisted ‘photographic memory’
|
|
US8775454B2
(en)
|
2008-07-29 |
2014-07-08 |
James L. Geer |
Phone assisted ‘photographic memory’
|
|
ES2338515B1
(es)
*
|
2008-11-06 |
2011-09-14 |
Consejo Superior De Investigaciones Cientifica (Csic) 80% |
Metodo de deteccion de la telangiectasia hemorragica hereditaria.
|
|
PE20230343A1
(es)
|
2015-12-11 |
2023-03-01 |
Immatics Biotechnologies Gmbh |
Peptidos que estimulan respuestas inmunitarias antitumorales
|